Pyridine and pyrazine derivatives as protein kinase modulators

Details for Australian Patent Application No. 2010277588 (hide)

Owner Novartis AG

Inventors Barsanti, Paul A.; Hu, Cheng; Jin, Jeff; Keyes, Robert; Kucejko, Robert; Lin, Xiaodong; Pan, Yue; Pfister, Keith B.; Sendzik, Martin; Sutton, James; Wan, Lifeng

Agent Davies Collison Cave

Pub. Number AU-A-2010277588

PCT Pub. Number WO2011/012661

Priority 61/357,720 23.06.10 US; 61/273,154 30.07.09 US

Filing date 28 July 2010

Wipo publication date 3 February 2011

International Classifications

C07D 213/74 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

19 January 2012 PCT application entered the National Phase

  PCT publication WO2011/012661 Priority application(s): WO2011/012661

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010277601-Dihydrobenzoindazoles

2010277582-Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients